Safety and Efficacy
 
 

Multiple Sclerosis MS Drugs Glossary The NET
 
Up
Carcinogenesis
Creutzfeldt-Jakob
Drug Interactions
Fertility
Hepatotoxic Agents
Nursing Mothers
Safety and Efficacy
 

 Home > [Multiple Sclerosis] > Multiple Sclerosis Drugs > Rebif > Rebif Side Effects > Rebif Unknowns > Safety and Efficacy
 

Multiple Sclerosis

Depression, suicidal ideation, and suicide attempts have been reported to occur with increased frequency in patients receiving interferon compounds.

Multiple Sclerosis (MS) Drugs

Rebif ®  Unknowns

(interferon beta-1a)
 
The safety and efficacy of Rebif ® beyond 2 years is unknown.

Efficacy of Rebif ® in chronic progressive or secondary progressive multiple sclerosis has not been established.
 

 
Reviewed July 2004

 

 
 

[SEARCH]
 
 

McFox's Multiple Sclerosis Pages
 
Send mail to Webmaster@themcfox.com with questions or comments about this web site.
Copyright © 2002 - 2004 McFox All Rights Reserved.
privacy policy